2025-07-31-accounts - Pharma Pollution Hub

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees’ Annual Report for the period

From 19[th] November 2024 to 31[st] July 2025

Charity name: Pharma Pollution Hub

Charity registration number: 1211006

Objectives and Activities

	SORP reference
Summary of the purposes of the charity as set out in its governing document	Para 1.17	The Pharma Pollution Hub (PPH) seeks to promote the conservation, protection and improvement of the environment from the negative effects of pharmaceutical pollution, and the sustainable transition towards pharmaceutical supply, use and waste management that is socially, economically and environmentally sustainable.
Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts.	Para 1.17 and 1.19	We undertake, procure, promote and disseminate the results of research which aims both to understand current pharmaceutical supply, use and waste management systems (their sustainability and societal-wide drivers and impacts), and to develop/implement pragmatic solutions to support the transition towards sustainability. We also provide appropriate information and advice, raise awareness of the issue of pharmaceutical sustainability, and bring together a wide range of public groups for inclusive discussions on this topic at community, regional, national and international levels.
Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit	Para 1.18	Throughout this first accounting year, the Trustees have had regard to the guidance on public benefit issued by the Charity Commission.

Additional information (optional)

You may choose to include further statements where relevant about:

SORP reference Para 1.38 Policy on grant making

Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other

Achievements and Performance

	SORP reference
Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole.	Para 1.20	We raised awareness of the issue of pharmaceutical sustainability and the need for action through giving presentations, providing advice via email and attending meetings with groups from across industry, government and the third sector. This included running a policy roundtable in the UK House of Lords. We also worked with stakeholders from the healthcare sector to publish apeer- reviewed article calling for greater action in the monitoring of pharmaceutical residues from hospitals. These activities were in line with our aim to support the societal transition towards more sustainable pharmaceutical supply, use and waste management, for long-term public and environmental benefit.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against objectives set	Para 1.41
Performance of fundraising activities against objectives set	Para 1.41

Investment performance against objectives	Para 1.41
Other

Financial Review

Financial Review
Review of the charity’s financial position at the end of the period	Para 1.21	The charity was dormant during this period (zero income and expenditure)
Statement explaining the policy for holding reserves stating why they are held	Para 1.22	N/A
Amount of reserves held	Para 1.22	£0
Reasons for holding zero reserves	Para 1.22	N/A
Details of fund materially in deficit	Para 1.24	N/A
Explanation of any uncertainties about the charity continuing as a going concern	Para 1.23	N/A

Additional information (optional)

You may choose to include further statements where relevant about:

The charity’s principal sources of funds (including any fundraising)	Para 1.47
Investment policy and objectives including any social investment policy adopted	Para 1.46
A description of the principal risks facing the charity	Para 1.46
Other

Structure, Governance and Management

Description of charity’s trusts:		N/A
Type of governing document (trust deed, royal charter)	Para 1.25	Foundation model constitution
How is the charity constituted? (e.g unincorporated association, CIO)	Para 1.25	CIO
Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees	Para 1.25	No new Trustees have been appointed, but any new Trustees would be selected and elected by the members of the Board of Trustees.

Additional information (optional)

You may choose to include further statements where relevant about:

Policies and procedures adopted for the induction and training of trustees	Para 1.51
The charity’s organisational structure and any wider network with which the charity works	Para 1.51
Relationship with any related parties	Para 1.51
Other

Reference and Administrative details

Charity name	Pharma Pollution Hub
Other name the charity uses	N/A
Registered charity number	1211006
Charity’s principal address	2 Barnfield Crescent Exeter EX1 1QT

Names of the charity trustees who manage the charity

Trustee name	Office (if any)	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee (ifany)
Charles Tyler	Chair	Wholeyear	N/A
Fiona Adshead		Wholeyear	N/A
Carol Routledge		Wholeyear	N/A
Victoria Robertson		Wholeyear	N/A
Sharon Pfleger		Wholeyear	N/A

– Corporate trustees names of the directors at the date the report was approved Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name	Dates acted if not for whole year
N/A

Funds held as custodian trustees on behalf of others

Description of the assets N/A held in this capacity

Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects

Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Type of Name Address adviser

Name of chief executive or names of senior staff members (Optional information)

Exemptions from disclosure

Reason for non-disclosure of key personnel details

N/A

Other optional information

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Charles Tyler Position (eg Secretary, Chair Chair, etc) Date 12[th] May 2026

Pharma Pollution Hub	Pharma Pollution Hub		1211006
Receipts andpayments accounts				CC16a
For the period from	11/19/2024	To	7/31/2025

Section A Receipts and payments

Section A Receipts and payments
A1 Receipts - - - - - - - - - - - Sub total - *Total receipts* 0 A3 Payments - - - - - - - - - Sub total - - - Sub total - *Total payments* 0 Net of receipts/(payments) - A5 Transfers between funds - A6 Cash funds last year end - *Cash funds this year end* 0 Unrestricted funds to the nearest £ *Sub total*(Gross income for AR) A2 Asset and investment sales, (see table). A4 Asset and investment purchases, (see table)	to the nearest £ - - - - - - - - - - - - 0 - - - - - - - - - - - - - 0 - - - 0 Restricted funds	to the nearest £ Endowment funds	Total funds to the nearest £ - - - - - - - - - - - - 0 - - - - - - - - - - - - - 0 - - - 0	Last year to the nearest £
		- - - - - - - - -	-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-

		- - -	-
			-	-
			-	-

		0	0	-

		- - - - - - - - - -	-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-
			-	-

		- - -	-
			-
			-	-

		0	0	-

	-	- - - 0	-	-
	-		-	-
	-		-	-
	0		0	-

Section B Statement of assets and liabilities at the end of the period

Details Details Details Details Details Signature #VALUE! *Total cash funds* (agree balances with receipts and payments account(s))	to nearest £ to nearest £ - - - - - - 0 0 OK OK to nearest £ to nearest £ - - - - - - - - - - - - Cost (optional) - - - - - Cost (optional) - - - - - - - - - - - - - - Print Name Charles Tyler Unrestricted funds Restricted funds Unrestricted funds Restricted funds Fund to which asset belongs Fund to which asset belongs Fund to which liability relates Amount due (optional)	to nearest £ Endowment funds
		-
		-
		-
		0
		OK
		to nearest £ Endowment funds
		-
		-
		-
		-
		-
		-
		Current value (optional)
		-
		-
		-
		-
		-
		Current value (optional)
		-
		-
		-
		-
		-
		-
		-
		-
		-
		When due (optional)






		Date of approval
#VALUE!	Charles Tyler	12th May2026